Background: Dimethandrolone (DMA) and 11β-methyl-19-nortestosterone (11β-MNT) are two novel compounds with both androgenic and progestational activity that are under investigation as potential male hormonal contraceptives. Their metabolic effects have never been compared in men.
Objective: Assess for changes in insulin sensitivity and adiponectin and compare the metabolic effects of these two novel androgens.